journal article·2023-11-15Open access

Oral Administration of Platinum Nanoparticles with SOD/CAT Cascade Catalytic Activity to Alleviate Ulcerative Colitis

Hao Liu, Yujie Zhang, Mingzhen Zhang, Zhaoxiang Yu, Mingxin Zhang

Journal of Functional Biomaterials· Volume 14· Issue 11

Abstract

Ulcerative colitis (UC) is a refractory chronic inflammatory disease involving the colon and rectum, falling under the category of inflammatory bowel disease (IBD). The accumulation of reactive oxygen species (ROS) in local tissues has been identified as a crucial contributor to the escalation of inflammatory responses. Therefore, eliminating ROS in the inflamed colon is a promising approach to treating UC. Nanomaterials with intrinsic enzyme-like activities (nanozymes) have shown significant therapeutic potential in UC. In this study, we found that platinum nanoparticles (Pt NPs) exhibited remarkable superoxide dismutase (SOD) and catalase (CAT) cascade catalytic activities, as well as effective hydroxyl radical (•OH) scavenging ability. The in vitro experiments showed that Pt NPs could eliminate excessive ROS to protect cells against oxidative stress. In the colitis model, oral administration of Pt NPs (loaded in chitosan/alginate hydrogel) could significantly alleviate UC, including reducing the colon length, the damaged epithelium, and the infiltration of inflammatory cells. Without appreciable systemic toxicity, Pt NPs represent a novel therapeutic approach to UC and are expected to achieve long-term inflammatory remission.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Advanced Nanomaterials in Catalysis · Nanoplatforms for cancer theranostics · Nanoparticles: synthesis and applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Second Clinical Medical College, Shaanxi University of Chinese Medicine, Xianyang 712046, China

School of Basic Medical Sciences, Xi’an Jiaotong University Health Science Center, Xi’an 710061, China

Department of General Surgery, The First Affiliated Hospital of Xi’an Medical University, Xi’an 710077, China

Department of Gastroenterology, The First Affiliated Hospital of Xi’an Medical University, Xi’an 710077, China

Funding

National Natural Science Foundation of China · the Innovation Team of Xi’an Medical University · the National Science Foundation of Shaanxi

References (69)

Show source-provided references
1. A comprehensive review and update on ulcerative colitis10.1016/j.disamonth.2019.02.004 ↗
3. Improving the care of inflammatory bowel disease (IBD) patients: Perspectives and strategies for IBD center management10.3904/kjim.2021.114 ↗
4. Incidence and Prevalence of Inflammatory Bowel Disease across Asia10.3349/ymj.2021.62.2.99 ↗
5. Estimated prevalence of ulcerative colitis and Crohn’s disease in Japan in 2014: An analysis of a nationwide survey10.1007/s00535-019-01603-8 ↗
6. Incidence and clinical characteristics of inflammatory bowel disease in a developed region of Guangdong Province, China: A prospective population-based study10.1111/jgh.12164 ↗
7. Inflammatory bowel disease: The role of environmental factors10.1016/j.autrev.2004.03.002 ↗
8. Targeting the complex interactions between microbiota, host epithelial and immune cells in inflammatory bowel disease10.1016/j.phrs.2016.09.044 ↗
9. Ferretti, F., Cannatelli, R., Monico, M.C., Maconi, G., and Ardizzone, S. (2022). An Update on Current Pharmacotherapeutic Options for the Treatment of Ulcerative Colitis. J. Clin. Med., 11.10.3390/jcm11092302 ↗
10. Combination therapy in inflammatory bowel disease: Current evidence and perspectives10.1016/j.intimp.2022.109545 ↗
11. The Future of IBD Therapy: Where Are We and Where Should We Go Next?10.1159/000443135 ↗
12. Acute pulmonary embolism following corticosteroid administration in acute severe ulcerative colitis with gastrointestinal bleeding: A case report10.3389/fcvm.2022.1018462 ↗
13. Impact of thiopurines on the natural history and surgical outcome of ulcerative colitis: A cohort study10.1136/gutjnl-2017-315521 ↗
14. Pathomechanisms of Oxidative Stress in Inflammatory Bowel Disease and Potential Antioxidant Therapies10.1155/2017/4535194 ↗
15. Review article: The role of oxidative stress in pathogenesis and treatment of inflammatory bowel diseases10.1007/s00210-014-0985-1 ↗
16. Oxidative Stress and DNA Damage: Implications in Inflammatory Bowel Disease
17. Guan, G., and Lan, S. (2018). Implications of Antioxidant Systems in Inflammatory Bowel Disease. Biomed. Res. Int., 2018.10.1155/2018/1290179 ↗
18. Superoxide dismutase nanozymes: An emerging star for anti-oxidation10.1039/D1TB00720C ↗
19. A review on antioxidants, prooxidants and related controversy: Natural and synthetic compounds, screening and analysis methodologies and future perspectives10.1016/j.fct.2012.09.021 ↗
20. Reactive oxygen species-based nanomaterials for the treatment of myocardial ischemia reperfusion injuries
21. Nanoenzymes in disease diagnosis and therapy10.1039/D0CC05427E ↗
22. Shape-Dependent Catalytic Activity of Platinum Nanoparticles in Colloidal Solution10.1021/nl0495256 ↗
23. Pharmacokinetics and preventive effects of platinum nanoparticles as reactive oxygen species scavengers on hepatic ischemia/reperfusion injury in mice10.1039/C4MT00018H ↗
24. Zheng, W., Jiang, B., Hao, Y., Zhao, Y., Zhang, W., and Jiang, X. (2014). Screening reactive oxygen species scavenging properties of platinum nanoparticles on a microfluidic chip. Biofabrication, 6.10.1088/1758-5082/6/4/045004 ↗
25. Polyvinylpyrrolidone (PVP) in nanoparticle synthesis10.1039/C5DT02964C ↗
26. Magnetic and self-healing chitosan-alginate hydrogel encapsulated gelatin microspheres via covalent cross-linking for drug delivery10.1016/j.msec.2019.04.012 ↗
27. An oral pH-activated "nano-bomb" carrier combined with berberine by regulating gene silencing and gut microbiota for site-specific treatment of ulcerative colitis10.1039/D1BM01765A ↗
28. Kim, Y., Zharkinbekov, Z., Raziyeva, K., Tabyldiyeva, L., Berikova, K., Zhumagul, D., Temirkhanova, K., and Saparov, A. (2023). Chitosan-Based Biomaterials for Tissue Regeneration. Pharmaceutics, 15.10.3390/pharmaceutics15030807 ↗
29. Oral Delivery of Pterostilbene by L-Arginine-Mediated "Nano-Bomb" Carrier for the Treatment of Ulcerative Colitis10.2147/IJN.S347506 ↗
30. Combination Therapy for Ulcerative Colitis: Orally Targeted Nanoparticles Prevent Mucosal Damage and Relieve Inflammation10.7150/thno.15710 ↗
31. Silencing of Intestinal Glycoprotein CD98 by Orally Targeted Nanoparticles Enhances Chemosensitization of Colon Cancer10.1021/acsnano.7b08499 ↗
32. A cascade nanoreactor for enhancing sonodynamic therapy on colorectal cancer via synergistic ROS augment and autophagy blockage10.1016/j.nantod.2023.101798 ↗
33. Characterization of Polymeric Nanoparticle Dispersions for Biomedical Applications: Size, Surface Charge and Stability10.2174/2211738506666180706121515 ↗
34. Evolution of the doping regimes in the Al-doped SnO2 nanoparticles prepared by a polymer precursor method10.1088/0953-8984/27/9/095301 ↗
35. Choi, H.J., Kim, S., Chu, E.K., Noh, B.R., Lee, W.S., Kwon, S.H., Oh, S., and Kim, K.K. (2019). Enhanced Photon Emission Efficiency Using Surface Plasmon Effect of Pt Nanoparticles in Ultra-Violet Emitter. Micromachines, 10.10.3390/mi10080528 ↗
36. Triphenylamine-based dye functionalized platinum colloid for photocatalytic hydrogen evolution from water: Synthesis, characterization, electron transfer, and photocatalysis10.1016/j.colsurfa.2014.05.069 ↗
37. Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles10.1039/c0nr00204f ↗
38. Nanozyme-mediated catalytic nanotherapy for inflammatory bowel disease10.7150/thno.33727 ↗
39. In vitro and in vivo characterization of pharmaceutical nanocarriers used for drug delivery10.1080/21691401.2018.1561457 ↗
40. Hydroxyl radical is a significant player in oxidative DNA damage in vivo10.1039/D1CS00044F ↗
41. The implications of oxidative stress and antioxidant therapies in Inflammatory Bowel Disease: Clinical aspects and animal models10.4103/1319-3767.173753 ↗
42. Real-time monitoring of cellular oxidative stress during aerosol sampling: A proof of concept study10.1080/01480545.2020.1774774 ↗
43. Toxicology of engineered nanomaterials: Focus on biocompatibility, biodistribution and biodegradation10.1016/j.bbagen.2010.04.007 ↗
44. Biocompatibility in regenerative nanomedicine10.2217/nnm-2019-0140 ↗
45. Nanoparticles for oral delivery: Targeted therapy for inflammatory bowel disease10.1039/D2TB01190E ↗
46. Liu, R., Gan, J., Du, M., Kong, X., Xu, C., Lü, Y., Cao, S., Meng, T., Wang, B., and Yu, T. (2023). Preparation and Characterization of Multilayer pH-Responsive Hydrogel Loaded Ganoderma lucidum Peptides. Foods, 12.10.3390/foods12071481 ↗
47. Nanoparticle distribution during systemic inflammation is size-dependent and organ-specific10.1039/C5NR03626G ↗
48. The spleen in local and systemic regulation of immunity10.1016/j.immuni.2013.10.010 ↗
49. Harold, K.M., MacCuaig, W.M., Holter-Charkabarty, J., Williams, K., Hill, K., Arreola, A.X., Sekhri, M., Carter, S., Gomez-Gutierrez, J., and Salem, G. (2022). Advances in Imaging of Inflammation, Fibrosis, and Cancer in the Gastrointestinal Tract. Int. J. Mol. Sci., 23.10.3390/ijms232416109 ↗
50. Ulcerative Colitis: Making the Diagnosis10.1016/j.gtc.2020.07.001 ↗
51. Disease clearance in ulcerative colitis: Setting the therapeutic goals for future in the treatment of ulcerative colitis10.3389/fmed.2022.1102420 ↗
52. Forty-Year Analysis of Colonoscopic Surveillance Program for Neoplasia in Ulcerative Colitis: An Updated Overview10.1038/ajg.2015.65 ↗
53. Ulcerative colitis-associated colorectal cancer10.3748/wjg.v20.i44.16389 ↗
54. What Does Disease Progression Look Like in Ulcerative Colitis, and How Might It Be Prevented?10.1053/j.gastro.2022.01.023 ↗
55. 5-aminosalicylate-intolerant patients are at increased risk of colectomy for ulcerative colitis10.1111/apt.16120 ↗
56. Kałużna, A., Olczyk, P., and Komosińska-Vassev, K. (2022). The Role of Innate and Adaptive Immune Cells in the Pathogenesis and Development of the Inflammatory Response in Ulcerative Colitis. J. Clin. Med., 11.10.3390/jcm11020400 ↗
57. Nanozymes: Created by learning from nature10.1007/s11427-019-1570-7 ↗
58. A Manganese-Superoxide Dismutase From Thermus thermophilus HB27 Suppresses Inflammatory Responses and Alleviates Experimentally Induced Colitis10.1093/ibd/izz097 ↗
59. Antioxidation and anti-inflammatory actions of the extract of Nitraria Tangutorum Bobr. fruits reduce the severity of ulcerative colitis in a dextran sulphate sodium-induced mice model10.1016/j.jff.2022.105005 ↗
60. Nanozymes as Enzyme Inhibitors10.2147/IJN.S294871 ↗
61. Zhang, B., Lv, Y., Yu, C., Zhang, W., Song, S., Li, Y., Chong, Y., Huang, J., and Zhang, Z. (2022). Au-Pt nanozyme-based multifunctional hydrogel dressing for diabetic wound healing. Biomater. Adv., 137.10.1016/j.bioadv.2022.212869 ↗
62. Platinum nanozymes recover cellular ROS homeostasis in an oxidative stress-mediated disease model10.1039/C5NR08358C ↗
63. Platinum nanoparticles Protect Against Lipopolysaccharide-Induced Inflammation in Microglial BV-2 Cells via Decreased Oxidative Damage and Increased Phagocytosis10.1007/s11064-021-03434-7 ↗
64. Preparation and use of nanogels as carriers of drugs10.1080/10717544.2021.1955042 ↗
65. Click hydrogels, microgels and nanogels: Emerging platforms for drug delivery and tissue engineering10.1016/j.biomaterials.2014.03.001 ↗
66. Reactive Oxygen Species (ROS)-Based Nanomedicine10.1021/acs.chemrev.8b00626 ↗
67. Reactive oxygen species (ROS) in macrophage activation and function in diabetes10.1016/j.imbio.2018.11.010 ↗
68. Geiß, C., Salas, E., Guevara-Coto, J., Régnier-Vigouroux, A., and Mora-Rodríguez, R.A. (2022). Multistability in Macrophage Activation Pathways and Metabolic Implications. Cells, 11.10.3390/cells11030404 ↗
69. Reactive oxygen species and immune regulation10.1080/08830185.2020.1768251 ↗